Published in
Elsevier, The Lancet Oncology, 11(15), p. 1215-1223
DOI: 10.1016/s1470-2045(14)70408-5
Links
- ORCID
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study
Journal article published in 2014 by
Daniel M. Green,
Wei Liu,
William H. Kutteh,
Raymond W. Ke,
Kyla C. Shelton,
Charles A. Sklar,
Wassim Chemaitilly,
Ching-Hon Pui,
James L. Klosky,
Sheri L. Spunt 
,
Monika L. Metzger,
DeoKumar Srivastava,
Kirsten K. Ness,
Leslie L. Robison,
Melissa M. Hudson
,
Monika L. Metzger,
DeoKumar Srivastava,
Kirsten K. Ness,
Leslie L. Robison,
Melissa M. Hudson
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Few data define the dose-specific relation between alkylating agent exposure and semen variables in adult survivors of childhood cancer. We undertook this study to test the hypothesis that increased exposure to alkylating agents would be associated with decreased sperm concentration in a cohort of adult male survivors of childhood cancer who were not exposed to radiation therapy for their childhood cancer.